Cytomorphology as a risk predictor: Experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage

Clinics in Laboratory Medicine

Volumn 25, Issue 4, 2005, Pages 827-843

  Masood, Shahla ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CELL STRUCTURE; CHEMOPROPHYLAXIS; CYTOLOGY; ENDOMETRIUM CANCER; HUMAN; LAVAGE; LUNG EMBOLISM; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; STROKE; TREATMENT OUTCOME;

BIOPSY, FINE-NEEDLE; BREAST; BREAST NEOPLASMS; CYTODIAGNOSIS; FEMALE; HUMANS; IRRIGATION; MAMMARY GLANDS, HUMAN; NIPPLES; PROGNOSIS; RISK FACTORS;

EID: 27944486579     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2005.08.014     Document Type: Review

References (60)

1. M.B. Sporn, and A.B. Roberts Role of retinoids in differentiation and carcinogens J Natl Cancer Inst 73 1984 1381 1387
2. C.E. Szarka, G. Grana, and P.F. Engstrom Chemoprevention of cancer Curr Probl Cancer 18 1994 6 79
3. L. Bernstein, R.K. Ross, and B.E. Henderson Prospects for the primary prevention of breast cancer Am J Epidemiol 135 1992 142 152
4. S.M. Lippman, S.E. Benner, and W.K. Hong Chemoprevention. Strategies for control of cancer Cancer 72 3 1993 984 990
5. R.L. Prentice, F. Kakar, and S. Hursting Aspects of the rational for the Women's Health Trail J Natl Cancer Inst 80 1988 802 814
6. U. Veronesi, G. De Palo, and A. Costa Chemoprevention of breast cancer with reinoids J Natl Cancer Inst Monogr 13 1992 93 97
7. B. Fisher, J.P. Constantine, and D.L. Wickerham Tamozifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study J Natl Cancer Inst 90 1998 1371 1388
8. L.C. Hartman, D.J. Schaid, and J.E. Woods Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer N Engl J Med 14 1999 71 84
9. T.R. Rebbeck, A.M. Levin, and A. Eisen Breast cancer after bilateral prophylactic oophorectomy in BRCA1 mutation carriers J Natl Cancer Inst 91 1999 1475 1479
10. N. Eby, J. Chang-Claude, and D.J. Bishop The familial and genetic susceptibility for breast cancer Cancer Causes Control 5 1994 458 470
11. S.A. Narod, D.A. Ford, and P. Devilee An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast cancer linkage consortium Am J Hum Genet 36 1995 254 264
12. W.D. Dupont, and D.L. Page Risk factors for breast cancer in women with proliferative breast disease N Engl J Med 312 1985 146 151
13. H.J. Wanebo, P.S. Feldman, and M.C. Wilhelm Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer Ann Surg 199 1984 569 578
14. S. Masood Cytopathology of the breast 1995 ASCP Press Chicago
15. S. Masood, E.R. Frykberg, and G.L. McLellan Cytologic differentiation between proliferative and nonproliferative breast disease in mammographically guided fine needle aspirates Diagn Cytopathol 7 1991 581 590
16. C.J. Marshall, G.B. Schumann, and J.H. Ward Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer Am J Clin Pathol 95 1991 157 165
17. B. Kilmer, C. Fabian, and D.D. Wallace Breast cancer chemoprevention trials using the fine-needle aspiration model J Cell Biochem 77 534 2000 7 12
18. S. Masood, and G. Rasty Potential value of cytology in the detection of breast cancer precursors by fine needle aspiration biopsy: the future Pap smear for breast cancer Acta Cytol 43 5 1999 890
19. S.A. Khan, S. Masood, and L. Miller Random fine needle aspiration of the breast of women at increased risk and standard risk controls Breast J 4 1998 420 425
20. C.J. Fabian, B.F. Kimler, and C.M. Zalles Short term breast cancer prediction by random periareolar fine needle aspiration cytology and the gail risk model J Natl Cancer Inst 92 2000 1217 1227
21. M. Wrensch, N.L. Petrakis, and E.B. King Breast cancer risk associated with abnormal cytology in nipple aspirates of breast fluids and prior history of breast biopsy Am J Epidemiol 137 1993 829 833
22. D.L. Page, W.D. Dupont, and W. Rogers Atypical hyperplastic lesions of the female breast, a long-term follow up study Cancer 55 1985 2698
23. W.D. Dupont, F.F. Parl, and W.H. Hartman Breast cancer risk associated with proliferative breast disease with atypical hyperplasia Cancer 71 1993 1258 1265
24. C.W. Boone, and G. Kelloff Biomarkers of premalignant breast disease and their use as surrogate endpoints in clinical trials of chemopreventive agents Breast J 1 1995 228 235
25. B.R. Dizura, and T.A. Bonfiglio Needle cytology of the breast Acta Cytol 23 1979 332 340
26. M. Bibbo, M. Scheiber, and R. Cajulius Sterotaxic fine needle aspiration cytology of occult malignant and premalignant breast lesions Acta Cytol 32 1988 193 201
27. S. Masood, E.R. Frykberg, and G.L. McClellan Prospective evaluation of radiologically detected fine needle aspiration biopsy of nonpalpable breast lesions Cancer 66 1990 1480 1487
28. S. Masood, N.M. Hardy, and N. Assof-Munasifi Cytologic grading system in diagnosis of high-risk and malignant breast lesions: merits and pitfalls Acta Cytol 38 1994 797 798
29. N. Sneige, and G.A. Staerkel Fine needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ Hum Pathol 25 1994 485 492
30. C.S. Abendroth, H.H. Wang, and B.S. Ducatman Comparative features of carcinoma in situ and atypical ductal hyperplasia of the breast on fine needle aspiration biopsy Am J Clin Pathol 96 1991 654 659
31. J. Silverman, S. Masood, and B.S. Ducatman Can FNA biopsy separate atypical hyperplasia, carcinoma in situ and invasive carcinoma of the breast? Cytomorphic criteria and limitations in diagnosis Diagn Cytopathol 9 1993 713 728
32. M. Sidawy, M. Stoler, and W. Frable Interobserver variability in the classification of proliferative breast lesions by fine needle aspiration: results of the Papanicolaou society of cytopathology study Diagn Cytopathol 18 2 1998 150 165
33. A.G. Dawson, D. Mulford, and L.A. Shiels Cytomorphology of proliferative breast disease Am J Clin Pathol 103 4 1995 438 442
34. M.A. Stanley, M.J. Henry-Stanley, and R. Zera Atypia in breast fine-needle aspiration smears correlates poorly with the presence of a prognastically significant proliferative lesion of ductal epithelium Hum Pathol 24 6 1993 630 635
35. S. Masood, L. Lu, and N. Assaf Munasifi Application of immunostaining for muscle specific actin for detection of myoepithelial cells in breast fine needle aspirates Diagn Cytopathol 13 1995 71 74
36. S. Masood, N.M. Hardy, and N. Assaf The value of muscle specific actin immunostaining in differentiation between atypical hyperplasia and carcinoma in breast fine needle aspirates Acta Cytol 38 5 1994 861
37. E.R. King, K.L. Chen, and L. Duarte Image cytometric classification of premalignant breast disease in fine-needle aspirates Cancer 62 1998 114 124
38. Rosai Borderline epithelial lesions of the breast Am J Surg Path 15 1991 209 221
39. S.J. Schnitt, J.L. Connoly, and F.A. Tavassoli Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standard criteria Am J Surgical Path 16 1992 1133 1143
40. D.D. Dershaw, E.A. Morris, and L. Liberman Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy Radiology 198 2 1996 313 315
41. A.J. Howat Final version. The uniform approach to breast fine needle aspiration biopsy Breast J 3 1997 149 168
42. S. Masood Diagnostic terminology in breast fine needle aspiration biopsy: redefining the term atypia Cancer 87 1 1999 1 4
43. J.P. Constantino, M.H. Gail, and D. Pee Validation studies for models projecting the risk of invasive and total breast cancer incidence J Natl Cancer Inst 91 1999 1541 1548
44. Rockhill B, Spiegelman D, Byrne C,, et al. Validation of the gail et al. Model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001;93:358-66.
45. W. Dooley, B.M. Ljung, and U. Veronesi Ductal lavage for detection of cellular atypia in women at high risk for breast cancer J Natl Cancer Inst 93 21 2001 1624 1632
46. J. O'Shaughnessy, B.M. Ljung, and W. Dooley Ductal lavage and the clinical management of women at high risk for breast carcinoma Cancer 94 2 2002 292 298
47. S. Masood, S. Khan, and S. Nayar Atypia in ductal lavage: a follow up experience with ductography, ductoscopy and tissue biopsy Mod Pathol 16 1 2003 40:168
48. R. Nayar, R. Ramakrishnan, and C. Baird Breast ductal lavage (DL): cytologic findings in 114 samples Lab Invest 76 2003 338
49. S. Masood, A.M. Siddiqi, and F. Payandeh Exfoliative breast cytopathology: an experience with ductal lavage Mod Pathol 76 51 2002 541
50. S. Masood Nipple, the new target Breast J 7 6 2001 377
51. th Annual National Interdisciplinary Breast Center Conference, February 27, 2005.
52. C.M. Noga, J.A. Brainard, and J.R. Dietz Ductoscopy in patients with pathologic nipple discharge: correlation of ductal lavage and duct excision findings Lab Invest 2002 82 83
53. E.R. Fisher, R.M. Gregoria, and B. Fisher The pathology of invasive breast cancer: a syllabus derived from findings of the national surgical adjuvant breast and bowel project (protocol no.4) Cancer 36 1975 1 85
54. S. Badve, E. Wiley, and N. Rodriguez Assessment of utility of ductal lavage and ductoscopy in breast cancer - a retrospective analysis of mastectomy specimens Mod Pathol 16 3 2003 206 209
55. E. Evron, W. Dooley, and C. Umbricht Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR Lancet 357 2001 1335 1336
56. D. Yamamoto, H. Senzaki, and H. Nakagawa Detection of chromosomal aneusomy by fluorescence in situ hybridization for patients with nipple discharge Cancer 97 2003 690 694
57. S.E. Mendrinos, J.D.L. Nolen, and T.M. Styblo Cytologic findings and protein expression profiles associated with ductal carcinoma of the breast in ductal lavage specimen using SELDI-TOF mass spectrometry Cancer 105 3 2005 178 183
58. C.J. Fabian, B.F. Kimler, and D. Brady A phase II breast cancer chemoprevention trial of oral x-difuovomethylornithine Clin Cancer Res 8 2002 3105 3117
59. G.R. Bean, V. Scott, and L. Yee Retinoic acid receptor-beta 2 promoter methylatin in random periareolar fine needle aspiration Cancer Epidemial Biomarkers Prev 14 4 2005 790 798
60. S. Masood Expanding role of breast cytopathology as a risk predictor Adv Anat Pathol 8 5 2001 225 263